ArticleClinical epigenetics2025
Comprehensive DNA methylation profiling of sperm in male partners of couples with unexplained recurrent pregnancy loss.
Article in Clinical epigenetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Sperm AluY Epimutations in Male Partners of Couples with Unexplained Recurrent Pregnancy Loss.bioRxiv : the preprint server for biology · 2026Article
- Recurrent Pregnancy Loss: A Couple-Based Framework for Integrating Paternal Assessment.Biomedicines · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundRecurrent pregnancy loss (RPL) affects fertility problems in approximately 5% of couples, while the cause of RPL remains unknown in about half RPL cases, which is also called unexplained RPL. The male factors were associated with RPL in male partners, including chromosome abnormality and sperm DNA fragmentation. DNA methylation is one of the most extensively studied epigenetic factors that could help elucidate the mechanism underlying RPL in male partners.
resultsWe revealed DNA methylation alternations occurring in sperm of RPL partners compared with the controls by genome-wide DNA methylation beadchip, including a series of differentially methylated CpG positions and genes. Importantly, we validated that the CpG site cg17985533 and the region chr11:1997780-1,997,899 from the H19 imprinted maternally expressed transcript were significantly hypermethylated in sperm of RPL-related men with > 10% mean methylation difference by targeted bisulfite sequencing. Moreover, the receiver operating characteristic analysis showed that CpG site cg17985533 and region chr11:1997780-1,997,899 could distinguish RPL-related men from controls, with an area under the curve of 0.7838 and 0.8125, sensitivity of 80% and 80%, and specificity of 80% and 75%, respectively. These results indicated that they could be potential biomarker for diagnosis of RPL in male partners.
conclusionsThis study highlighted the importance of H19 gene methylation in differentiating RPL-related men and control, and provided new insight for revealing potential epigenetic mechanisms for RPL in male partners.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.